The 2022 global Metagenomic Market reached a size of USD 1.41 Billion and is projected to demonstrate a revenue CAGR of 16.5% throughout the forecast period, as stated in the latest report from Reports and Data.
Metagenomic sequencing is a technique that empowers researchers to delve into the collective DNA of multiple organisms within a complex sample, offering a more comprehensive understanding of microbial communities and their impacts on various systems.
The metagenomic sector is experiencing growth primarily due to two factors: the increasing incidence of infectious diseases and the need for accurate and rapid diagnostic tools. Metagenomic sequencing plays a crucial role in the realm of pandemic surveillance and management by revealing new viruses and variants, a demand that has surged in light of the COVID-19 pandemic.
Access Free sample PDF Copy of the Report @
https://www.reportsanddata.com/download-free-sample/6668
Furthermore, there is a growing demand for personalized medicine, a need that metagenomic analysis can help meet. This demand is driven by the rising prevalence of chronic conditions such as cancer, diabetes, and cardiovascular disorders.
Key players in the Metagenomic Market:
- Qiagen NV.
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Becton, Dickinson, and Company
- Merck KGaA
- Bruker Corporation
- Oxford Nanopore Technologies Ltd.
- PerkinElmer, Inc.
- Zymo Research Corporation
Some Key Highlights in the Report:
- In 2021, the most lucrative sector was sequencing, which involves determining the nucleotide sequence of DNA or RNA molecules. This method is widely employed in metagenomic research due to its ability to provide essential insights into the taxonomic and functional diversity of microbial communities. The high demand for metagenomic sequencing services can be attributed to the increased utilization of next-generation sequencing (NGS) technology and the expansion of sequencing platforms. Additionally, the growth of this market is being propelled by intensified research efforts focused on comprehending the role of microbiomes in human health, agriculture, and environmental management.
- During the same year, the environmental monitoring segment recorded the highest revenue share. Environmental monitoring encompasses the analysis of microbial populations in diverse habitats, including soil, water, and air. The comprehensive understanding of the biodiversity, functional potential, and environmental impact of these microbial communities heavily relies on metagenomic research. This market is driven by the necessity for sustainable resource management and mounting concerns about environmental deterioration. Furthermore, the growth of this market is bolstered by increasing demand for microbial-based products and services across various sectors such as biotechnology, food and beverage, and pharmaceuticals.
- In the global metagenomic market, North America currently holds a significant share due to escalating research and development expenditures, supportive government regulations, and growing collaborations between academic institutions and major industry players. Within North America, the United States is anticipated to dominate the market owing to the presence of key market players, substantial investments in genomics research, the adoption of advanced sequencing technologies, the demand for personalized healthcare solutions, and heightened public awareness regarding the benefits of metagenomics in disease diagnosis.
- In 2021, Illumina, Inc. made headlines by acquiring Grail, Inc., a company specializing in early cancer detection through blood-based tests. This acquisition was aimed at strengthening Illumina’s position in the oncology market and enhancing its capabilities in genomic sequencing.
- In 2020, Qiagen NV announced a strategic partnership with NeuMoDx Molecular, Inc., a company specializing in molecular diagnostic testing. The collaboration was intended to develop and market a fully integrated system for infectious disease testing.
Get in detailed Research Study @
https://www.reportsanddata.com/report-detail/metagenomic-market
For the purpose of this report, Reports and Data has segmented the global metagenomic market on the basis of Product Type Outlook, Application Outlook, and Regional Outlook:
Product Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Sequencing
- Bioinformatics
- Data Analysis
- Others
Application Outlook (Revenue, USD Billion; 2022 – 2032)
- Clinical Diagnosis
- Environmental Monitoring
- Agriculture
- Others
Download Summary @ https://www.reportsanddata.com/download-summary-form/6668
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Ask for Customize Research Report @
https://www.reportsanddata.com/request-customization-form/6668
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Ultrasound Market by Product Type (2D, 3D/4D, Doppler, HIFU, and Others), By Application (Diagnostic, Obstetrics/Gynecology, Cardiology, Oncology, and Others), and By Region Forecast to 2032
Hysteroscope Market Size, Share, Trends, By Type (Flexible, Rigid), By Application (Myomectomy, Endometial Ablation, Polypectomy), By End-use (Gynecology Clinics, Ambulatory Surgical Centers), By Region Forecast To 2030
Psoriasis Drugs Market, By Drug Class (Biologics, Systemic Therapy, and Topical Therapy), By Route of Administration (Oral, Injectable, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region Forecast to 2032
Arthroscopic Devices Market by Product Type (Arthroscopes, Fluid Management Systems, RF Ablation Systems, Others), By Application (Knee, Shoulder, Hip, Spine, Others), By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-metagenomic-market